SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Share Price Crosses Below 200-Day Moving Average – Should You Sell?

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH – Get Free Report) shares crossed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $62.38 and traded as low as $61.96. SPDR S&P Pharmaceuticals ETF shares last traded at $62.15, with a volume of 120,171 shares trading hands.

SPDR S&P Pharmaceuticals ETF Price Performance

The business has a 50-day simple moving average of $64.88 and a two-hundred day simple moving average of $62.38. The stock has a market cap of $490.99 million, a price-to-earnings ratio of 17.94 and a beta of 0.62.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of XPH. Bank of America Corp DE increased its position in SPDR S&P Pharmaceuticals ETF by 128.0% during the 1st quarter. Bank of America Corp DE now owns 811,939 shares of the company’s stock worth $43,918,000 after buying an additional 455,802 shares during the period. Parkway Wealth Management Group LLC acquired a new position in SPDR S&P Pharmaceuticals ETF during the third quarter valued at approximately $24,754,000. Envestnet Portfolio Solutions Inc. lifted its stake in SPDR S&P Pharmaceuticals ETF by 5.3% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 180,521 shares of the company’s stock worth $11,963,000 after purchasing an additional 9,042 shares during the last quarter. First Citizens Bank & Trust Co. acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF in the 3rd quarter valued at $11,083,000. Finally, Private Advisor Group LLC bought a new position in shares of SPDR S&P Pharmaceuticals ETF in the 3rd quarter valued at $6,685,000.

SPDR S&P Pharmaceuticals ETF Company Profile

(Get Free Report)

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

See Also

Receive News & Ratings for SPDR S&P Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.